Derek Yoon serves as President & CEO of Solasta Ventures, a Boston-based venture capital firm that operates as the U.S. See sector focus and contact routes.
Derek Yoon serves as President & CEO of Solasta Ventures, a Boston-based venture capital firm that operates as the U.S. subsidiary of South Korea’s Aju IB Investment, where he leads investments in early-stage U.S. life science companies with novel science. His investment thesis targets early-stage therapeutics and drug-discovery platforms addressing diseases with significant unmet medical needs, focusing specifically on U.S.-based biotechnology and healthcare startups. While specific check sizes and lead/follow behavior are not publicly detailed, he actively leads cross-border strategic partnerships leveraging relationships with top-tier Korean pharmaceutical companies. Notable portfolio companies include Arcellx, Apellis, Arvinas, and Axonis Therapeutics, with Yoon serving as a board member at Arcellx, Carbon Biosciences, EvolveImmune Therapeutics, and Trefoil Therapeutics. Before Solasta, Yoon spent over twenty years in alternative investments and healthcare corporate banking, including roles at Kibo Capital, RBS Healthcare Banking Group, and Berwind Private Equity. He holds an MBA from Babson College, an MSF from Boston College, and a B.S. in Chemical Eng
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Boston.
Investors like Derek Yoon · Full investor directory · Investor access · Company funding database